Perkins Capital Management’s Inogen INGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-199,600
Closed -$1.23M 85
2026
Q1
$1.23M Sell
199,600
-18,050
-8% -$111K 1.16% 23
2025
Q4
$1.46M Buy
217,650
+14,850
+7% +$111K 1.16% 25
2025
Q3
$1.66M Buy
202,800
+54,750
+37% +$409K 1.46% 21
2025
Q2
$1.04M Buy
+148,050
New +$996K 1.05% 29
2022
Q2
Sell
-6,700
Closed -$217K 110
2022
Q1
$217K Hold
6,700
0.18% 86
2021
Q4
$228K Buy
+6,700
New +$243K 0.15% 90
2020
Q1
Sell
-3,775
Closed -$258K 113
2019
Q4
$258K Buy
+3,775
New +$237K 0.23% 83

Other funds holding INGN

Perkins Capital Management's INGN Position: Q2 2026 in Review

Perkins Capital Management sold out of Inogen (INGN) in Q2 2026, closing a stake of 199,600 shares — an estimated $1.23M sold.

Perkins Capital Management first reported a position in INGN in Q4 2019 and held it in 7 quarters. The position peaked at $1.66M in Q3 2025. 129 funds tracked by Wall St. Rank hold INGN as of Q2 2026.

  • Perkins Capital Management reported no remaining Inogen position as of Q2 2026 after selling out during the quarter.
  • Perkins Capital Management sold 199,600 Inogen shares in Q2 2026, an estimated $1.23M.
  • Perkins Capital Management first reported a position in Inogen in Q4 2019 and held it in 7 quarters.
  • Perkins Capital Management's Inogen position peaked at $1.66M in Q3 2025.
  • 129 funds tracked by Wall St. Rank held Inogen as of Q2 2026.

Based on Perkins Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.